Agonistic Monoclonal Antibodies Potentiate Tumorigenic and Invasive Activities of Splicing Variant of the RON Receptor Tyrosine Kinase
Cancer Biology and Therapy - United States
doi 10.4161/cbt.5.9.3073
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2006
Authors
Publisher
Informa UK Limited